3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Melanoma
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Uveal Melanoma
2
Osteosarcoma
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Interventions
Bevacizumab
3
ribociclib
2
Temozolomide
2
Radiotherapy
2
Radiation
2
Panobinostat
2
pembrolizumab
1
dipinacoline glutamate
1
dinutuximab
1
cemiplimab
1
adavosertib
1
abemaciclib
1
Vorinostat
1
Valproic Acid
1
Re-Irradiation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nivolumab
1
Maintenance
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Everolimus
1
Erlotinib Hydrochloride
1
Congresses as Topic
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diffuse Intrinsic Pontine Glioma
×
Colony-Stimulating Factors
×
Clear all
No trials found.